|
⚲
|
| Keyboard |
| Turn Therapeutics Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0002023016 |
| Sale | 2026-08-14 (1.6 M Sold) |
| Fund | |
| Phone | 8185644011 |
| Address | 250 North Westlake Blvd Westlake Village, CA 91362 |
| Source | [EDGAR] |
| Amount Raised ($k) |
|---|
| Company Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Form D Offering | |
|---|---|
| Filed | 2026-08-26 (D) |
| Exemption | 506(b) |
| Minimum | $15,000 |
| Remaining | Indefinite |
| Duration | One year or less |
| Revenue | Decline to Disclose |
| In the News | |
|---|---|
| Thu, 23 Jul 2026 | Zacks Research Upgrades Turn Therapeutics ( NASDAQ : TTRX ) to Hold — themarketsdaily.com |
| Tue, 07 Jul 2026 | Why Is Turn Therapeutics Stock Trading Higher Today ? - Turn Therapeutics ( NASDAQ : TTRX ) — benzinga.com |
| Sun, 14 Jun 2026 | Head - To - Head Review : Turn Therapeutics ( NASDAQ : TTRX ) & Acerus Pharmaceuticals ( OTCMKTS : ASPCF ) — themarketsdaily.com |
| Sat, 13 Jun 2026 | Turn Therapeutics ( NASDAQ : TTRX ) Trading Up 9 . 5 % – Should You Buy ? — dailypolitical.com |
| Tue, 02 Jun 2026 | Turn Therapeutics Reports Interim Phase 2 GX - 03 Data In Atopic Dermatitis ; Stock Up — rttnews.com |
| Directors | Role | 2011 - 2026 |
|---|---|---|
| Neilesh Ghodadra | Executive Officer | |
| Kent Kester | Director | |
| Arthur Golden | Director | |
| Andrew Gengos | Director | |
| Martin Dewhurst | Director | |
| Zuraiz Chaudhary | Executive Officer | |
| Bradley Burnam | Executive Officer |
| Comparable Firms | State | AUM |
|---|---|---|
|
Institutional Venture Management XVII LLC
✚
|
CA | |
|
The Social Capital Partnership LLC
✚
|
CA | |
|
Otherwise Fund Management LLC
✚
|
CA | |
|
Bullpen Management LLC
✚
|
CA | |
|
Type One Management LLC
✚
|
CA | |
|
Hanabi Capital Management LLC
✚
|
CA | |
|
Liquid 2 Ventures LLC
✚
|
CA | |
|
Canvas Management Company LLC
✚
|
CA | |
|
Good Friends LLC
✚
|
CA | |
|
MNS Global Capital Managers LLC
✚
|
CA |